219 related articles for article (PubMed ID: 27924680)
1. Atomic insight into designed carbamate-based derivatives as acetylcholine esterase (AChE) inhibitors: a computational study by multiple molecular docking and molecular dynamics simulation.
Mohammadi T; Ghayeb Y
J Biomol Struct Dyn; 2018 Jan; 36(1):126-138. PubMed ID: 27924680
[TBL] [Abstract][Full Text] [Related]
2. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
[TBL] [Abstract][Full Text] [Related]
3. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors.
Gharaghani S; Khayamian T; Ebrahimi M
SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
6. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
Ghosh S; Chandar NB; Jana K; Ganguly B
J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
[TBL] [Abstract][Full Text] [Related]
7. Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
Ţînţaş ML; Gembus V; Alix F; Barré A; Coadou G; Truong L; Sebban M; Papamicaël C; Oulyadi H; Levacher V
Eur J Med Chem; 2018 Jul; 155():171-182. PubMed ID: 29886321
[TBL] [Abstract][Full Text] [Related]
8. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
9. Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study.
Rocha REO; Lima LHF
J Biomol Struct Dyn; 2019 Apr; 37(7):1843-1856. PubMed ID: 29697300
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of fullerene derivatives as novel potent inhibitors of protein acetylcholinesterase without catalytic active site interaction: insight into the inhibitory mechanism through molecular modeling studies.
Wan Y; Guan S; Qian M; Huang H; Han F; Wang S; Zhang H
J Biomol Struct Dyn; 2020 Feb; 38(2):410-425. PubMed ID: 30706763
[TBL] [Abstract][Full Text] [Related]
11. In silico approaches to evaluate the molecular properties of organophosphate compounds to inhibit acetylcholinesterase activity in housefly.
Marimuthu P; Lee YJ; Kim B; Seo SS
J Biomol Struct Dyn; 2019 Feb; 37(2):307-320. PubMed ID: 29322868
[TBL] [Abstract][Full Text] [Related]
12. The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.
Zhang Y; Zhang S; Xu G; Yan H; Pu Y; Zuo Z
Mol Biosyst; 2016 Nov; 12(12):3734-3742. PubMed ID: 27801451
[TBL] [Abstract][Full Text] [Related]
13. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
Lee S; Barron MG
Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
[TBL] [Abstract][Full Text] [Related]
14. Computational insight into the phthalocyanine-DNA binding via docking and molecular dynamics simulations.
Ozalp L; Sağ Erdem S; Yüce-Dursun B; Mutlu Ö; Özbil M
Comput Biol Chem; 2018 Dec; 77():87-96. PubMed ID: 30245350
[TBL] [Abstract][Full Text] [Related]
15. Study on the active ingredients of Shenghui decoction inhibiting acetylcholinesterase based on molecular docking and molecular dynamics simulation.
Li Z; Shi H
Medicine (Baltimore); 2023 Sep; 102(38):e34909. PubMed ID: 37746985
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
[TBL] [Abstract][Full Text] [Related]
17. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
18. Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies.
Ali MR; Sadoqi M; Møller SG; Boutajangout A; Mezei M
J Mol Graph Model; 2017 Sep; 76():36-42. PubMed ID: 28711758
[TBL] [Abstract][Full Text] [Related]
19. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations.
Honorio P; Sainimnuan S; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2021 Aug; 344():109523. PubMed ID: 34033838
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
Liu HR; Liu XJ; Fan HQ; Tang JJ; Gao XH; Liu WK
Bioorg Med Chem; 2014 Nov; 22(21):6124-33. PubMed ID: 25260958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
